Endocrine, Metabolic & Immune Disorders - Drug Targets

(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Editor-in-Chief:

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Back

Become EABM
Become Reviewer

Retinoids as Critical Modulators of Immune Functions: New Therapeutic Perspectives for Old Compounds

Volume:9   Issue: 2
Pp: 113-131
Michele Montrone, Debora Martorelli, Antonio Rosato and Riccardo Dolcetti
DOI: 10.2174/187153009788452435

T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions

Volume:9   Issue: 2
Pp: 132-144
Andrea Honscheid, Lothar Rink and Hajo Haase
DOI: 10.2174/187153009788452390

The AKT Axis as a Therapeutic Target in Autoimmune Diseases

Volume:9   Issue: 2
Pp: 145-150
Tianfu Wu and Chandra Mohan
DOI: 10.2174/187153009788452417

Impact of IL-17 on Cells of the Monocyte Lineage in Health and Disease

Volume:9   Issue: 2
Pp: 178-186
S. Sergejeva and A. Linden
DOI: 10.2174/187153009788452444

Inflammatory Bowel Disease and Celiac Disease: Overlaps in the Pathology and Genetics, and their Potential Drug Targets

Volume:9   Issue: 2
Pp: 199-218
Eleonora A.M. Festen, Agata M. Szperl, Rinse K. Weersma, Cisca Wijmenga and Martin C. Wapenaar
DOI: 10.2174/187153009788452426